| Literature DB >> 31717364 |
Dmitry Deryabin1, Anna Galadzhieva1, Dianna Kosyan1, Galimjan Duskaev1.
Abstract
Numerous gram-negative phytopathogenic and zoopathogenic bacteria utilise acylated homoserine lactone (AHL) in communication systems, referred to as quorum sensing (QS), for induction of virulence factors and biofilm development. This phenomenon positions AHL-mediated QS as an attractive target for anti-infective therapy. This review focused on the most significant groups of plant-derived QS inhibitors and well-studied individual compounds for which in silico, in vitro and in vivo studies provide substantial knowledge about their modes of anti-QS activity. The current data about sulfur-containing compounds, monoterpenes and monoterpenoids, phenylpropanoids, benzoic acid derivatives, diarylheptanoids, coumarins, flavonoids and tannins were summarized; their plant sources, anti-QS effects and bioactivity mechanisms have also been summarized and discussed. Three variants of plant-derived molecules anti-QS strategies are proposed: (i) specific, via binding with LuxI-type AHL synthases and/or LuxR-type AHL receptor proteins, which have been shown for terpenes (carvacrol and l-carvone), phenylpropanoids (cinnamaldehyde and eugenol), flavonoid quercetin and ellagitannins; (ii) non-specific, by affecting the QS-related intracellular regulatory pathways by lowering regulatory small RNA expression (sulphur-containing compounds ajoene and iberin) or c-di-GMP metabolism reduction (coumarin); and (iii) indirect, via alteration of metabolic pathways involved in QS-dependent processes (vanillic acid and curcumin).Entities:
Keywords: AHL-mediated QS; bacterial virulence; biofilm; natural compounds; phytochemicals; quorum sensing (QS); quorum sensing inhibitors
Mesh:
Substances:
Year: 2019 PMID: 31717364 PMCID: PMC6888686 DOI: 10.3390/ijms20225588
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Plant-derived compounds with proved modes of action on AHL-mediated quorum sensing in bacteria.
| IUPAC (Trivial) Names of the Compounds Structural Formulas | Plants Source | Anti-QS Effects | Modes of Action | References |
|---|---|---|---|---|
|
| ||||
| (E)-1-(Prop-2-enyldisulfanyl)-3-prop-2-enylsulfinylprop-1-ene (Ajoene) | Inhibition of QS-regulated virulence factors (elastase, rhamnolipid, pyocyanin) and biofilm formation in | Lowering expression of GacA-dependent small regulatory RNAs (RsmY and RsmZ) | [ | |
| 1-isothiocyanato-3-methylsulfinylpropane (Iberin) | Blocking of QS-regulated features, matrix rhamnolypid biosynthesis and biofilm formation in | Inhibition of GacA-dependent small regulatory RNAs (RsmY and RsmZ); lowering the abundance of the LadS protein (GacS activator) | [ | |
|
| ||||
| 2-methyl-5-propan-2-ylphenol (Carvacrol) | Inhibition of QS-regulated violacein biosynthesis and chitinase activity in | Binding to LuxI-type synthase (ExpI) and LuxR-type transcriptional regulator (ExpR) | [ | |
| 2-methyl-5-prop-1-en-2-ylcyclohex-2-en-1-one ( | Inhibition of QS-regulated swinging/swarming motility and reduction of AHL production in | Binding to LuxI-type synthase (HalI) and LuxR-type transcriptional regulator (HalR) | [ | |
|
| ||||
| (2 | Inhibition of QS-regulated virulence factors (protease, elastase, pyocyanin) and biofilm formation in | Binding to LuxR-type receptor proteins and/or interaction with LuxI-type synthase (LasI) | [ | |
| 2-Methoxy-4-(prop-2-en-1-yl)phenol (Eugenol) | Inhibitory effects on QS-biosensors; inhibition of QS-regulated elastase, protease, pyocyanin and pyoverdine biosynthesis in | Binding to LuxR-type proteins (LasR and ExpR); down-regulation of AHL synthases genes ( | [ | |
|
| ||||
| 4-hydroxy-3-methoxybenzoic acid (Vanillic acid)
| Inhibition of QS-regulated virulence and biofilm formation in | Changing the proteins content involved in S-layers, protease, prodigiosin and lipase production, targeting flagella, amino acids, carbohydrates and fatty acids biosynthesis | [ | |
|
| ||||
| (1E,6E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione (Curcumin) | Inhibition of QS-regulated violacein biosynthesis in | Interaction with LuxI-type synthases; down-regulation of LuxI-type and LuxR-type proteins genes ( | [ | |
|
| ||||
| 2 | Inhibitory effects on QS-biosensors; inhibition of violacein biosynthesis in | Reduction of c-di-GMP metabolism | [ | |
|
| ||||
| 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4 | Inhibition of QS-regulated bioluminescence in | Binding to LuxR-type receptor proteins (LasR, RhlR and CviR) | [ | |
|
| ||||
| (46 | Inhibition of QS-controlled genes and QS-regulated virulence factors in | Interaction with QS-related proteins (including LuxI-type syntheses) via precipitation mechanism; bioactivity may be explained by secondary hydrolyzed and metabolized products | [ | |
Figure 1A schematic view of the strategies which phytochemicals use to combat AHL-mediated QS in bacteria.